Synapsoft logo
AI Insights from Disclosures
Searching...
MOA Life Plus Co. Ltd. 142760
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
MOA Life Plus Co. Ltd. engages in the biopharmaceutical new drug development business using its own platform technology as its core business, together with a consumer business in health functional foods and cosmetics, and a distribution business for prescription drugs and medical supplies. For the development of new drug candidates, the company holds a pipeline spanning various stages from basic research to clinical research using its proprietary platform technologies (HumaMAX®, MucoMAX®), and it has established and operates an overseas joint venture (Quintrigen) for anticancer drug development.
Representative Director Han Sangjin
Founded December 30, 1999
Corporation Type KOSDAQ
Industry Classification Research and experimental development on natural sciences and engineering
Corporate number 16011-0091332
Business number 314-81-29870
Phone Number 031-280-9650
Fax Number 031-280-9660
Company Address 767 Sinsu-ro, Suji-gu, Yongin-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant